Published: Sep 25, 2024
+ +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ +diff --git a/products/jonathan_schwarz/index.html b/2024/08/15/PINNACLENews/index.html similarity index 68% rename from products/jonathan_schwarz/index.html rename to 2024/08/15/PINNACLENews/index.html index 8e1c14bb..c3dacfe7 100644 --- a/products/jonathan_schwarz/index.html +++ b/2024/08/15/PINNACLENews/index.html @@ -4,33 +4,31 @@
-TxGNN Published in Nature Medicine
+ + +Published: Sep 25, 2024
+ +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ +Three Papers Accepted to NeurIPS
+ + +Published: Sep 27, 2024
+ +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + +Reach out to the reading group coordinator (Wanxiang Shen, <WanXiang_Shen@hms.harvard.edu>) with questions, comments, and suggestions.
+Reach out to the reading group coordinator (Zhenglun Kong) with questions and suggestions.
Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Dr. Zitnik co-founded Therapeutics Data Commons and is the faculty lead of the AI4Science initiative.
-Dr. Zitnik is the recipient of the 2022 Young Mentor Award at Harvard Medical School.
+Dr. Zitnik is the recipient of the 2022 Young Mentor Award at Harvard Medical School.
Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Thank you for being so interested in joining our group! Impactful research requires excellent mentoring. Prof. Zitnik is the recipient of the Young Mentor Award at Harvard Medical School—this prestigious award acknowledges that recognition to her.
+Thank you for being so interested in joining our group! Impactful research requires excellent mentoring. Prof. Zitnik is the recipient of the Young Mentor Award at Harvard Medical School—this prestigious award acknowledges that recognition to her.
We have multiple openings for postdoctoral research fellows in the broad area of foundation models focusing on geometric deep learning, multimodal learning, large-scale knowledge graphs, large language models, generative AI, and AI agents.
+We have multiple openings for postdoctoral research fellows in foundation models focusing on geometric deep learning, multimodal learning, large-scale knowledge graphs, large language models, generative AI, and AI agents.
-Applications are reviewed on a rolling basis. Interested candidates are encouraged to submit their applications as soon as possible.
+This position is available immediately. Interested candidates are encouraged to submit their applications as soon as possible.
NOW OPEN: Request For Applications
@@ -198,7 +198,7 @@We have an opening for a postdoctoral research fellowship in novel methods in the broad area of medical AI.
+We have multiple openings for postdoctoral research fellows in medical AI.
This position is available immediately. Interested candidates are encouraged to submit their applications as soon as possible.
@@ -259,6 +259,118 @@Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Sep 2022: Self-Supervised Pre-Training at NeurIPS 2022
- - -New paper on self-supervised contrastive pre-training accepted at NeurIPS 2022. Project page. Thankful for this collaboration with the Lincoln National Laboratory.
- - - - - -Sep 2022: Best Paper Honorable Mention Award at IEEE VIS
- - -Our paper on user-centric AI of drug repurposing received the Best Paper Honorable Mention Award at IEEE VIS 2022. Thankful for this collaboration with Gehlenborg Lab.
- - - - - -Sep 2022: Multimodal Representation Learning with Graphs
- - -New preprint! We present the blueprint for graph-centric multimodal learning.
- - - - - -Aug 2022: On Graph AI for Precision Medicine
- - -The recording of our tutorial on using graph AI to advance precision medicine is available. Tune into four hours of interactive lectures about state-of-the-art graph AI methods and applications in precision medicine.
- - - - - -Sep 2022: Self-Supervised Pre-Training at NeurIPS 2022
+ + +New paper on self-supervised contrastive pre-training accepted at NeurIPS 2022. Project page. Thankful for this collaboration with the Lincoln National Laboratory.
+ + + + + +Sep 2022: Best Paper Honorable Mention Award at IEEE VIS
+ + +Our paper on user-centric AI of drug repurposing received the Best Paper Honorable Mention Award at IEEE VIS 2022. Thankful for this collaboration with Gehlenborg Lab.
+ + + + + +Sep 2022: Multimodal Representation Learning with Graphs
+ + +New preprint! We present the blueprint for graph-centric multimodal learning.
+ + + + + +Aug 2022: On Graph AI for Precision Medicine
+ + +The recording of our tutorial on using graph AI to advance precision medicine is available. Tune into four hours of interactive lectures about state-of-the-art graph AI methods and applications in precision medicine.
+ + + + + +Apr 2021: Representation Learning for Biomedical Nets
- - -In our survey on representation learning for biomedical networks we discuss how long-standing principles of network biology and medicine provide the conceptual grounding for representation learning, explain its successes, and inform future advances.
- - - - - -Mar 2021: Receiving Amazon Research Award
- - -We are excited about receiving Amazon Faculty Research Award on Actionable Graph Learning for Finding Cures for Emerging Diseases. Thank you to Amazon Science for supporting our research.
- - - - - -Mar 2021: Michelle's Graduate Research Fellowship
- - -Michelle M. Li won the NSF Graduate Research Fellowship Award. Congratulations!
- - - - - -Mar 2021: Hot Off the Press: Multiscale Interactome
- - -Hot off the press! We develop a multiscale interactome approach to explain disease treatments. The approach can predict drug-disease treatments, identify proteins and biological functions related to treatment, and identify genes that alter treatment’s efficacy and adverse reactions.
- - - - - -Apr 2021: Representation Learning for Biomedical Nets
+ + +In our survey on representation learning for biomedical networks we discuss how long-standing principles of network biology and medicine provide the conceptual grounding for representation learning, explain its successes, and inform future advances.
+ + + + + +Mar 2021: Receiving Amazon Research Award
+ + +We are excited about receiving Amazon Faculty Research Award on Actionable Graph Learning for Finding Cures for Emerging Diseases. Thank you to Amazon Science for supporting our research.
+ + + + + +Mar 2021: Michelle's Graduate Research Fellowship
+ + +Michelle M. Li won the NSF Graduate Research Fellowship Award. Congratulations!
+ + + + + +Mar 2021: Hot Off the Press: Multiscale Interactome
+ + +Hot off the press! We develop a multiscale interactome approach to explain disease treatments. The approach can predict drug-disease treatments, identify proteins and biological functions related to treatment, and identify genes that alter treatment’s efficacy and adverse reactions.
+ + + + + +PhD Student
PhD Student
PhD Student
Harvard-MIT HST
PhD Student
PhD Student
Harvard CCB
PhD Student
PhD Student
MIT EECS
PhD Student
PhD Student
Harvard BIG
PhD Student
PhD Student
Harvard BBS
Postdoctoral Fellow
Harvard Berkowitz Fellow
Postdoctoral Fellow
Postdoctoral Fellow
Harvard Berkowitz Fellow
Postdoctoral Fellow
Postdoctoral Fellow
Postdoctoral Fellow
Research Associate
Postdoctoral Fellow
Research Associate
Postdoctoral Fellow
Harvard Data Science Fellow
Research Associate
Visiting PhD Student
Research Associate
Graduate Researcher
Research Associate
Undergraduate Researcher
Harvard
Undergraduate Researcher
Harvard
Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -We are looking for applicants with demonstrably strong research skills, ideally, with multiple publications in top venues in machine learning and artificial intelligence, and/or top-tier scientific journals.
-Candidates must have a Ph.D. or equivalent degree in computer science, statistics, or a closely related field. Strong programming skills and practical experience with leading machine learning frameworks are required. Experience and/or interest in applications of AI to science, biology and medicine is a strong plus.
+Candidates must have a Ph.D. or equivalent degree in computer science. Strong programming skills and practical experience with leading machine learning frameworks are required. Experience and/or interest in applications of AI to science, biology and medicine is a strong plus.
Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -We are looking for applicants with demonstrably strong research skills, ideally, with multiple publications in top venues in machine learning and artificial intelligence, and/or top-tier medical journals.
-Candidates must have a Ph.D. or equivalent degree in computer science, statistics, or a closely related field. Strong programming skills and practical experience with leading machine learning frameworks are required. Experience and/or interest in medical AI is a strong plus.
+Candidates must have a Ph.D. or equivalent degree in computer science. Strong programming skills and practical experience with leading machine learning frameworks are required. Experience and/or interest in medical AI is a strong plus.
Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -UniTS
-Unified Time Series Model that Can Process Various Tasks Across Multiple Domains with Shared Parameters and Does Not Have any Task-Specific Modules
+A Unified Multi-Task Time Series Model
@@ -390,7 +390,7 @@TxGNN
-Zero-Shot Prediction of Therapeutic Use with Geometric Deep Learning and Clinician Centered Design
+A Foundation Model for Clinician Centered Drug Repurposing
@@ -1743,6 +1743,118 @@Sep 2024: Three Papers Accepted to NeurIPS
+ + +Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.
+ + + + + +Sep 2024: TxGNN Published in Nature Medicine
+ + +Graph foundation model for drug repurposing published in Nature Medicine. [Harvard Gazette] [Harvard Medicine News] [Forbes]
+ + + + + +Aug 2024: Graph AI in Medicine
+ + +Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.
+ + + + + +Aug 2024: How Proteins Behave in Context
+ + +Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.
+ + + + + +Jan 2024: AI's Prospects in Nature Machine Intelligence
- - -We discussed AI’s 2024 prospects with Nature Machine Intelligence, covering LLM progress, multimodal AI, multi-task agents, and how to bridge the digital divide across communities and world regions.
- - - - - - -Jan 2024: Combinatorial Therapeutic Perturbations
- - -New paper introducing PDGrapher for combinatorial prediction of chemical and genetic perturbations using causally-inspired neural networks.
- - - - - - -Nov 2023: Next Generation of Therapeutics Commons
- - -We are building the next generation of Therapeutics Commons! We are seeking outstanding fellows who will lead AI research to advance molecular drug design and clinical drug development.
- - - - - - -Oct 2023: Structure-Based Drug Design
- - -Geometric deep learning has emerged as a valuable tool for structure-based drug design, to generate and refine biomolecules by leveraging detailed three-dimensional geometric and molecular interaction information.
- - - - - - -